INS and Insulin resistance: These proinflammatory markers, as well as CRP, are suggested to induce insulin resistance and gluconeogenesis, subsequent hyperglycemia, and attenuate insulin signaling and sensitivity through insulin receptor substrate phosphorylation [46–50].